Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines

Pollard, Charlotte, Rejman, Joanna, De Haes, Winni, Verrier, Bernard, Van Gulck, Ellen, Naessens, Thomas, De Smedt, Stefaan, Bogaert, Pieter +3 more·2013·Molecular Therapy

Cited by (248)

Items 101–200 of 248

  1. Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV
    Kevin E. Lindsay, Daryll A. Vanover, Merrilee Thoresen, Heath H King, Peng Xiao, Peres Ramos Badial, Mariluz Araínga, Seong Bin Park, Pooja Munnilal Tiwari, Hannah E. Peck et al. · 2020 · Molecular Therapy
  2. Nanoparticle-based delivery strategies of multifaceted immunomodulatory RNA for cancer immunotherapy
    Yeon Jeong Yoo, Chang Hoon Lee, Sei Hyun Park, Yong Taik Lim · 2022 · Journal of Controlled Release
  3. The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system
    Marie‐Clotilde Bernard, Emilie Bazin, Nadine Petiot, Katia Lemdani, Sylvie Commandeur, Cécile Verdelet, Sylvie Margot, Vladimir Perkov, Manon Ripoll, Marie Garinot et al. · 2023 · Molecular Therapy — Nucleic Acids
  4. Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration
    Guevara, Maria L., Jilesen, Zachary, Stojdl, David, Persano, Stefano · 2019 · ACS Omega
  5. Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
    Yuan Yuan, Fan Gao, Ying Chang, Qiu Zhao, Xingxing He · 2023 · Biomarker Research
  6. Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment
    Theofilus A. Tockary, Saed Abbasi, Miki Matsui-Masai, Akimasa Hayashi, Naoto Yoshinaga, Eger Boonstra, Zheng Wang, Shigeto Fukushima, Kazunori Kataoka, Satoshi Uchida · 2023 · Proceedings of the National Academy of Sciences
  7. Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement
    Marleen Bérouti, Mirko Wagner, Wilhelm Greulich, Ignazio Piseddu, Jan Gärtig, Larissa Hansbauer, Christoph Müller-Hermes, Matthias Heiß, Alexander Pichler, Annika J. Tölke et al. · 2025 · Cell
  8. Principles and Challenges in anti-COVID-19 Vaccine Development
    Zuzana Ozaniak Strizova, Jitka Smetanová, Jiřina Bartůňková, Tomáš Milota · 2021 · International Archives of Allergy and Immunology
  9. Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines
    Maria L. Guevara, Stefano Persano, Francesca Persano · 2019 · Current Pharmaceutical Design
  10. mRNA vaccine designs for optimal adjuvanticity and delivery
    Yuki Mochida, Satoshi Uchida · 2024 · RNA Biology
  11. Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination.
    I. Tombácz, D. Weissman, N. Pardi · 2021 · Methods in molecular biology
  12. The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration
    Van Hoecke, Lien, Roose, Kenny, Ballegeer, Marlies, Zhong, Zifu, Sanders, Niek N., De Koker, Stefaan, Saelens, Xavier, Van Lint, Sandra · 2020 · Molecular Therapy Nucleic Acids
  13. mRNA vaccines: a new era in vaccine development
    Shubhra Chandra, Jennifer C Wilson, David M. Good, Ming Qian Wei · 2024 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  14. Non-viral gene delivery strategies for gene therapy: a “ménage à trois” among nucleic acids, materials, and the biological environment
    Daniele Pezzoli, Gabriele Candiani · 2013 · Journal of Nanoparticle Research
  15. Messenger <scp>RNA</scp>‐based vaccines: progress, challenges, applications
    Kramps, Thomas, Probst, Jochen · 2013 · WIREs RNA
  16. Nanoengineered targeting strategy for cancer immunotherapy
    Weimin Yin, Yuwei Li, Yunqing Gu, Min Luo · 2020 · Acta Pharmacologica Sinica
  17. Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs
    Zhong, Zifu, McCafferty, Séan, Opsomer, Lisa, Wang, Haixiu, Huysmans, Hanne, De Temmerman, Joyca, Lienenklaus, Stefan, Portela Catani, João Paulo, Combes, Francis, Sanders, Niek N. · 2021 · Molecular Therapy
  18. Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine
    Xing Duan, Yi Zhang, Mengran Guo, Na Fan, Kepan Chen, Shugang Qin, Wen Xiao, Qian Zheng, Hai Huang, Xiawei Wei et al. · 2022 · Acta Pharmaceutica Sinica B
  19. Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)
    Alberto Crespo Guardo, Patrick Tjok Joe, Laia Miralles, Manel Enric Bargalló, Beatriz Mothe, Ahmet Krasniqi, Carlo Heirman, Felipe García, Kris Thielemans, Christian Brander et al. · 2016 · AIDS
  20. mRNA Cancer Vaccines—Messages that Prevail
    Christian R. Grunwitz, Lena M. Kranz · 2017 · Current topics in microbiology and immunology
  21. Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
    Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli, Dong Liang Yu · 2021 · Current topics in microbiology and immunology
  22. Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods
    Bryce M. Warner, David Safronetz, Gary P. Kobinger · 2016 · Advances in experimental medicine and biology
  23. The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
    Nitika, Jiao Wei, Ai‐Min Hui · 2021 · Infection and Drug Resistance
  24. A lipid-based LMP2-mRNA vaccine to treat nasopharyngeal carcinoma
    Mengran Guo, Xing Duan, Xingchen Peng, Zhaohui Jin, Hai Huang, Wen Xiao, Qian Zheng, Yongqi Deng, Na Fan, Kepan Chen et al. · 2023 · Nano Research
  25. Novel synthetic plasmid and Doggybone™ DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice
    Veronica L. Scott, Ami R. Patel, Daniel O. Villarreal, Scott E. Hensley, Edwin Ragwan, Jian Yan, Niranjan Y. Sardesai, Paul J. Rothwell, Jonathan P Extance, Lisa J. Caproni et al. · 2015 · Human Vaccines & Immunotherapeutics
  26. Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions
    Mohd Sayeed Shaikh, Md. Faiyazuddin, Mubasshera Sabir Khan, Shahbaz K. Pathan, Imran J. Syed, Amol Dilip Gholap, Mohammad Shabib Akhtar, Ranjit Sah, Rachana Mehta, Sanjit Kumar Sah et al. · 2024 · Frontiers in Microbiology
  27. Polylactide-Based Reactive Micelles as a Robust Platform for mRNA Delivery
    Céline Lacroix, Almudena Humanes, Céline Coiffier, Didier Gigmès, Bernard Verrier, Thomas Trimaille · 2020 · Pharmaceutical Research
  28. Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
    Nicholas M. Provine, Paul Klenerman · 2022 · European Journal of Immunology
  29. Chitosan-Crosslinked Low Molecular Weight PEI-Conjugated Iron Oxide Nanoparticle for Safe and Effective DNA Delivery to Breast Cancer Cells
    Guanyou Lin, Jianxi Huang, Mengyuan Zhang, Shanshan Chen, Miqin Zhang · 2022 · Nanomaterials
  30. Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials
    Iman Karimi-Sani, Zahra Molavi, Samaneh Naderi, Seyedeh Habibeh Mirmajidi, Iman Zare, Yasaman Naeimzadeh, Atena Mansouri, Amir Tajbakhsh, Amir Savardashtaki, Amirhossein Sahebkar · 2024 · Journal of Nanobiotechnology
  31. The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
    Reese Jalal Ladak, Alexander J. He, Yu-Hsun Huang, Yu Ding · 2022 · Frontiers in Immunology
  32. mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions
    Ryo Okuyama · 2023 · Vaccines
  33. Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral Administration
    Antje Ziller, Sara S. Nogueira, Eva Huehn, Sérgio S. Funari, Gerald Brezesinski, Hermann Hartmann, Uğur Şahin, Heinrich Haas, Peter Langguth · 2017 · Molecular Pharmaceutics
  34. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans
    Fredrika Hellgren, Anja Rosdahl, Rodrigo Arcoverde Cerveira, Klara Lenart, Sebastian Ols, Yong-Dae Gwon, Seta Kurt, Anna Maria Delis, Gustav Joas, Magnus Evander et al. · 2024 · JCI Insight
  35. mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
    Yu Gao, Liang Yang, Zhenning Li, Xueqiang Peng, Hangyu Li · 2024 · Biomarker Research
  36. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate
    Aline Yen Ling Wang · 2021 · International Journal of Molecular Sciences
  37. An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses
    Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Wei Yu, Xia Jin · 2022 · Virologica Sinica
  38. In Vitro Transcribed mRNA Vaccines with Programmable Stimulation of Innate Immunity
    Kristin H. Loomis, Kevin E. Lindsay, Chiara Zurla, Sushma M. Bhosle, Daryll A. Vanover, Emmeline L. Blanchard, Jonathan L. Kirschman, Ravi V. Bellamkonda, Philip J. Santangelo · 2018 · Bioconjugate Chemistry
  39. mRNA-Based Vaccines and Mode of Action
    Janina Gergen, Benjamin Petsch · 2020 · Current topics in microbiology and immunology
  40. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2
    Daniela Cornelia Călina, Antonio F. Hernández, Thomas Härtung, Alexey M. Egorov, Boris Nikolaevich Izotov, Τaxiarchis Κonstantinos Νikolouzakis, Aristidis Michael Tsatsakis, Panayiotis G. Vlachoyiannopoulos, Anca Oana Docea · 2021 · Life
  41. Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
    Navami Prabhakar Koyande, Rupali Srivastava, Ananya Padmakumar, Aravind Kumar Rengan · 2022 · Vaccines
  42. Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
    Yalan Liu, Yuncheng Li, Qinxue Hu · 2023 · Vaccines
  43. Harnessing Topology and Stereochemistry of Glycidylamine‐Derived Lipid Nanoparticles for in Vivo mRNA Delivery to Immune Cells in Spleen and Their Application for Cancer Vaccination
    Mahmoud M. Abd Elwakil, Ryota Suzuki, Alaa M. Khalifa, Rania M. Elshami, Takuya Isono, Yaser Hosny Ali Elewa, Yusuke Sato, Takashi Nakamura, Toshifumi Satoh, Hideyoshi Harashima · 2023 · Advanced Functional Materials
  44. Advances in mRNA vaccines
    Mengyun Li, Zining Wang, Chunyuan Xie, Xiaojun Xia · 2022 · International review of cytology
  45. mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
    Alireza Shariati, Pouria Khani, Farzad Nasri, Hamed Afkhami, Arya Khezrpour, Sina Kamrani, Fatemeh Sadat Shariati, Sajad Alavimanesh, Mohammad Hossein Modarressi · 2024 · Biomarker Research
  46. Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer
    Meike-Kristin Abraham, Karlheinz Peter, Tatjana Michel, Hans Peter Wendel, Stefanie Krajewski, Xiaowei Wang · 2017 · Nanotheranostics
  47. Advancing mRNA technologies for therapies and vaccines: An African context
    Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
  48. Transient pacing in pigs with complete heart block via myocardial injection of mRNA coding for the T-box transcription factor 18
    David W. Wolfson, Nam Kyun Kim, Ki Hong Lee, Jared P. Beyersdorf, Jonathan J. Langberg, Natasha Fernandez, Dahim Choi, Nadine Zureick, Tae Yun Kim, Seongho Bae et al. · 2024 · Nature Biomedical Engineering
  49. Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases
    Yihan Lu, Ciying Qian, Yang Huang, Tianyu Ren, Wuzhi Xie, Ningshao Xia, Shaowei Li · 2025 · International Journal of Biological Macromolecules
  50. Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs
    Kristin H. Loomis, Jonathan L. Kirschman, Sushma M. Bhosle, Ravi V. Bellamkonda, Philip J. Santangelo · 2015 · Journal of Materials Chemistry B
  51. Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
    Vijayakumar Jawalagatti, Perumalraja Kirthika, John Hwa Lee · 2022 · Frontiers in Immunology
  52. Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach
    Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, Aklank Jain, P. Hemachandra Reddy, Gurjit Kaur Bhatti, Jasvinder Singh Bhatti · 2023 · Advanced Therapeutics
  53. Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?
    Alberto Rubio‐Casillas, David Cowley, Mikolaj Raszek, Vladimir Nikolaevich Uversky, Elrashdy M Moustafa Mohamed Redwan · 2024 · International Journal of Biological Macromolecules
  54. Engineered biomaterials for development of nucleic acid vaccines
    H. J. Yang, Yan Li, Shubin Jin, Jing Xu, Paul C. Wang, Xing‐Jie Liang, Xin Zhang · 2015 · Biomaterials Research
  55. PLGA cationic nanoparticles, obtained from nano-emulsion templating, as potential DNA vaccines
    Eduard Soler Besumbes, C. Fornaguera, M. Monge, M. García-Celma, Javier Carrión, C. Solans, A. Dols-Pérez · 2019 · European Polymer Journal
  56. Nanoparticle-based delivery platforms for mRNA vaccine development
    Sezer Okay, Öznur Özge Özcan, Mesut Karahan · 2020 · AIMS Biophysics
  57. The mRNA vaccine, a swift warhead against a moving infectious disease target
    Sheema Mir, Mohammad Ayoub Mir · 2024 · Expert Review of Vaccines
  58. The mRNA component of LNP-mRNA vaccines triggers IFNAR-dependent immune activation which attenuates the adaptive immune response
    Liat Bar‐On, Hila Cohen, Uri Elia, Lilach Cherry, Ofer Cohen, Noam Erez A · 2025 · Frontiers in Immunology
  59. Oligonucleotide separation techniques for purification and analysis: What can we learn for today's tasks?
    Robert Minkner, Jirayu Boonyakida, Enoch Y. Park, Hermann Wätzig · 2022 · Electrophoresis
  60. Low-Dose Mildronate-Derived Lipidoids for Efficient mRNA Vaccine Delivery with Minimal Inflammation Side Effects
    Jiwei Liu, Bing Xiao, Yong‐Le Yang, Yifan Jiang, Rui Wang, Wei Dong Qi, Yixuan Pan, Yuping Chen, Huimin Wang, Jiaqi Fan et al. · 2024 · ACS Nano
  61. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA
    Laura Taina-González, María de la Fuente · 2022 · Pharmaceutics
  62. mRNA-based therapies: Preclinical and clinical applications
    Musga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, Sarah E. Knudsen, Farrukh Vohidov, Andoni Garitano-Trojaola · 2022 · International review of cytology
  63. Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway
    Weiqian Dai, Man Xing, Lingjin Sun, Lihui Lv, Xiang Wang, Yihan Wang, Xueyang Pang, Yingying Guo, Jiling Ren, Dongming Zhou · 2024 · Journal of Virology
  64. β-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model
    Anna Laura Nelson, Chiara Mancino, Xueqin Gao, Joshua A. Choe, Laura S. Chubb, Katherine B. Williams, Molly E. Czachor, Ralph Marcucio, Francesca Taraballi, John P. Cooke et al. · 2024 · Bioactive Materials
  65. RNA-Based Vaccination: Sending a Strong Message
    David B. Weiner · 2013 · Molecular Therapy
  66. Proximity Ligation Assays for In Situ Detection of Innate Immune Activation: Focus on In Vitro-Transcribed mRNA
    Emmeline L. Blanchard, Kristin H. Loomis, Sushma M. Bhosle, Daryll A. Vanover, Patrick Baumhof, Bruno Pitard, Chiara Zurla, Philip J. Santangelo · 2018 · Molecular Therapy — Nucleic Acids
  67. Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV
    Sigrid D’haese, Céline Lacroix, Felipe García, Montserrat Plana, Simona Maria Ruță, Guido L. Vanham, Bernard Verrier, Joeri L. Aerts · 2020 · Journal of Controlled Release
  68. Programmed polymersomes with spatio-temporal delivery of antigen and dual-adjuvants for efficient dendritic cells-based cancer immunotherapy
    Hanyong Wang, Xinyu Yang, Chunyan Hu, Chenlu Huang, Hai Wang, Dunwan Zhu, Linhua Zhang · 2022 · Chinese Chemical Letters
  69. RNA cancer vaccines: developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy
    Hongxia Zhang, Xiaojun Xia · 2021 · Human Vaccines & Immunotherapeutics
  70. Advancement in the development of mRNA ‐based vaccines for respiratory viruses
    Tays Troncoso‐Bravo, Mario A. Ramírez, Ricardo A. Loaiza, Carolina Román-Cárdenas, Georgios Papazisis, Daniel A. Garrido, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis · 2024 · Immunology
  71. The progress of tumor vaccines clinical trials in non-small cell lung cancer
    Xiaomu Wang, Yunping Niu, Fang Bian · 2024 · Clinical & Translational Oncology
  72. Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies
    Munazza Fatima, Timothy An, Kee‐Jong Hong · 2025 · Biomolecules
  73. Nanomaterials Based on Lipids for Vaccine Development
    Ana Maria Carmona‐Ribeiro · 2016 · Elsevier eBooks
  74. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans
    Keshav Goyal, Harsh Goel, Pritika Baranwal, Anisha Tewary, Aman Dixit, Avanish Kumar Pandey, Mercilena Benjamin, Pranay Tanwar, Abhijit Dey, Fahad Khan et al. · 2021 · Immuno
  75. Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination
    Benjamin Kahn, Sokratis A. Apostolidis, Vatsal Bhatt, Allison R. Greenplate, Staci Kallish, Anthony F. LaCava, Alfredo Lucas, Nuala J. Meyer, Dan Negoianu, Alexis Ogdie et al. · 2021 · Critical Care Explorations
  76. Zika virus—an update on the current efforts for vaccine development
    Victória Alves Santos Lunardelli, Juliana de Souza Apostólico, Edgar Ruz Fernandes, Daniela Santoro Rosa · 2020 · Human Vaccines & Immunotherapeutics
  77. Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
    Wubetu Yihunie Belay, Getinet Nibret, Yibeltal Aschale · 2023 · Clinical Pharmacology Advances and Applications
  78. Advances and Strategies in Enhancing mRNA Cancer Vaccines
    Miao Zhang, Shengqi Chen, Hai-Jun Hu, Yenhui Ong, Qianqian Ni · 2025 · Advanced Materials
  79. Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA
    Zhigang Zhang, Dazhi Cheng, Wenqin Luo, Donling Hu, Tiantian Yang, Kaixuan Hu, Li Liang, Wei Liu, Jianping Hu · 2024 · Molecules
  80. Practical Considerations for Next-Generation Adjuvant Development and Translation
    William R. Lykins, Christopher B. Fox · 2023 · Pharmaceutics
  81. Enhanced Skin Wound Healing Through Chemically Modified Messenger RNA Encoding Epidermal Growth Factor ( EGF )
    Haiyang Hu, Qianglong Sheng, Fan Yang, Xinyi Wu, Youlai Zhang, Shuling Wu, Yihu Liu, Ningyan Hu, Chenhong Fu, Jialin Leong et al. · 2025 · International Wound Journal
  82. Efficient Induction of Antigen-Specific CD8+ T-Cell Responses by Cationic Peptide-Based mRNA Nanoparticles
    Sigrid D’haese, Thessa Laeremans, Sabine den Roover, Sabine Danielle Allard, Guido L. Vanham, Joeri L. Aerts · 2022 · Pharmaceutics
  83. An LNP-mRNA vaccine protects fish against rhabdovirus infection
    Camille Ayad, Dean Porter, Elise Lambert, Pierre Libeau, Céline Coiffier, Valentine Ginet, Bertrand Collet, Jean‐Pierre Levraud, Pierre Boudinot, Bernard Verrier · 2025 · Vaccine
  84. Emerging trends of research on mRNA vaccines: A co-citation analysis
    Juan Chen, Ting Zhang, Yan Zhen Lu, Xiaoyi Yang, Zhaolian Ouyang · 2022 · Human Vaccines & Immunotherapeutics
  85. Development of Gene-Based Vectors for Immunization
    David B. Weiner, Gary J. Nabel · 2017 · Elsevier eBooks
  86. mRNA Vaccination: An Outlook on Innate Sensing and Adaptive Immune Responses
    Janan Shoja Doost, Fatemeh Fazel, Nitish Boodhoo, Shayan Sharif · 2024 · Viruses
  87. mRNA vaccines against infectious diseases and future direction
    Muhammad Tahir Aleem, Furqan Munir, Amna Shakoor, Fenfei Gao · 2024 · International Immunopharmacology
  88. Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation
    Carolina Medina‐Montano, Maximiliano L. Cacicedo, Malin Svensson, María José Limeres, Yanira Zeyn, Jean Emiro Chaves-Giraldo, Nadine Röhrig, Stephan Grabbe, Stephan Gehring, Matthias Bros · 2022 · International Journal of Molecular Sciences
  89. RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
    Mohammad Natami, Amirsasan Gorgzadeh, Arsalan Gholipour, Seyedeh Narges Fatemi, Nima Firouzeh, Maryam Zokaei, Saad Hasan Mohammed Ali, Hadis Kheradjoo, Somayeh Sedighi, Omid Gholizadeh et al. · 2024 · Journal of Nanobiotechnology · Retracted
  90. Streamlined and on-demand preparation of mRNA products on a universal integrated platform
    Hongjuan Wei, Zhen Rong, Liyan Liu, Ye Sang, Jing Yang, Shengqi Wang · 2023 · Microsystems & Nanoengineering
  91. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database
    Hassan Hussein Musa, Taha Hussein Musa · 2022 · Human Vaccines & Immunotherapeutics
  92. Supramolecular Gene Transfection Agents
    Bruno Pitard, Damien Habrant · 2016 · Elsevier eBooks
  93. Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
    Lorena Leonardelli, Giuseppe Lofano, Gianluca Selvaggio, Silvia Parolo, Stefano Giampiccolo, Danilo Tomasoni, Enrico Domenici, Corrado Priami, Haifeng Song, Duccio Medini et al. · 2021 · Frontiers in Immunology
  94. mRNA technology for the prevention and treatment of HIV-1 infection
    Chuang LIU, Alexey V. Yaremenko, Xiaolong Li, Xinru You, Xiaoyu Zhu, Nuo Liu, Wei Chen, Na Kong, Tian Xie, Gaurav D. Gaiha et al. · 2026 · Nature Reviews Bioengineering
  95. Effect of cationic and neutral lipids in cationic liposomes on antibody production induced by systemic administration of mRNA lipoplexes into mice
    Yoshiyuki Hattori, Min Tang · 2024 · Journal of Drug Delivery Science and Technology
  96. The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs
    Sigrid D’haese, Sabine den Roover, Rein Verbeke, Ilke Aernout, Sofie Meulewaeter, Joëlle Cosyns, Jessy Meert, Sarah Vanbellingen, Thessa Laeremans, Ine Lentacker et al. · 2024 · Molecular Therapy — Nucleic Acids
  97. Highly pure mRNA vaccine provides robust immunization against P. aeruginosa by minimizing type I interferon responses
    Ken Kawaguchi, Le Bui Thao Nguyen, Mao Kinoshita, Naoko Abe, Makoto Oba, Hiroshi Abe, Kazuki Sudo, Keita Inoue, Satoshi Uchida, Teiji Sawa · 2025 · Journal of Controlled Release
  98. Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer
    Jean‐François Rossi, Patrick Frayssinet, Maksim Matciyak, Nikolai Nikolaevich Tupitsyn · 2024 · Cancer Biology and Medicine
  99. Modern vaccine strategies for emerging zoonotic viruses
    Atif Ahmed, Muhammad Safdar, Samran Sardar, Sahar Yousaf, Fiza Farooq, Ali Raza, Muhammad Shahid, Kausar A. Malik, Samia Afzal · 2022 · Expert Review of Vaccines
  100. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials